'Aspirin a colon fix'.A NEW super aspirin super aspirin Cardiology A popular term for any agent–eg, antiplatelet GP IIb/IIIa receptor antagonist–orbofiban, sibrafiban, xemilofiban; SA relieves angina and ↓ risks of acute MI, but may be less effective than aspirin in preventing blood is being tested as a possible anti-cancer drug. US scientists who developed nitroaspirin found it tackled colon cancer in lab animals without causing internal bleeding and kidney damage. They will now test it out on 240 patients over three years. Prof Basil Rigas, of Stony Brook University The State University of New York at Stony Brook (SUNYSB), also known as Stony Brook University (SBU) is a public research university located in Stony Brook, New York (on the north side of Long Island, about 55 miles east of Manhattan, New York). , New York, said: "It is hundreds to thousands of times more potent than aspirin in inhibiting the growth of colon cancer cells and quite effective in preventing the development of colon cancer." |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion